best performing large cap stocks from 11/5/2013 to 7/20/2015

Neurocrine Biosciences (NBIX) had the highest return between November 5, 2013 and July 20, 2015 by a large-cap US stock, returning 464.1%.

ASSET DATE % RETURN
Neurocrine Biosciences (NBIX)
11/5/2013 - 7/20/2015
464.09%
Celsius (CELH)
11/5/2013 - 7/20/2015
400%
Palo Alto Networks (PANW)
11/5/2013 - 7/20/2015
347.23%
Skyworks Solutions (SWKS)
11/5/2013 - 7/20/2015
305.61%
Broadcom (AVGO)
11/5/2013 - 7/20/2015
206.82%
DexCom (DXCM)
11/5/2013 - 7/20/2015
197.29%
Electronic Arts (EA)
11/5/2013 - 7/20/2015
191.81%
Incyte (INCY)
11/5/2013 - 7/20/2015
185.78%
Mr Cooper (COOP)
11/5/2013 - 7/20/2015
184.16%
Centene (CNC)
11/5/2013 - 7/20/2015
158.8%
Monster Beverage (MNST)
11/5/2013 - 7/20/2015
151.27%
Illumina (ILMN)
11/5/2013 - 7/20/2015
149.68%
Edwards Lifesciences (EW)
11/5/2013 - 7/20/2015
143.53%
Alnylam Pharmaceuticals (ALNY)
11/5/2013 - 7/20/2015
141.47%
Biomarin Pharmaceutical (BMRN)
11/5/2013 - 7/20/2015
136.83%
NetEase (NTES)
11/5/2013 - 7/20/2015
132.92%
Manhattan Associates (MANH)
11/5/2013 - 7/20/2015
132.77%
Netflix (NFLX)
11/5/2013 - 7/20/2015
130.63%
Genmab A-S (GMAB)
11/5/2013 - 7/20/2015
125.07%
CyberArk Software (CYBR)
11/5/2013 - 7/20/2015
119.92%
Zebra Technologies (ZBRA)
11/5/2013 - 7/20/2015
119.56%
AerCap (AER)
11/5/2013 - 7/20/2015
117.5%
NXP Semiconductors (NXPI)
11/5/2013 - 7/20/2015
113.29%
XPO Logistics (XPO)
11/5/2013 - 7/20/2015
112.83%
Fortinet (FTNT)
11/5/2013 - 7/20/2015
112.42%
Large-cap stocks are treated as having a market cap of $10B+.